Log in or Sign up for Free to view tailored content for your specialty!
Infection Control News
Cannabis use linked to lower ART adherence in older adults with HIV
Cannabis use was linked to a lower ART adherence among older patients with HIV compared with patients who never use the drug, according to a study published in Open Forum Infectious Diseases.
Vaccine coverage among US kindergarteners declines again
The percentage of kindergarteners who had received certain routine childhood immunizations declined again last school year, CDC researchers reported Thursday.
Log in or Sign up for Free to view tailored content for your specialty!
Uganda declares end of Ebola outbreak that killed 55
Health officials on Wednesday declared an end to an Ebola outbreak in Uganda that killed 55 people and infected at least 142 in less than 4 months.
FDA will review monoclonal antibody for RSV protection in infants
The FDA will review a biologics license application for nirsevimab for the prevention of respiratory syncytial virus in newborns and infants, according to Sanofi and AstraZeneca, which are developing the monoclonal antibody.
Top in ID: Effectiveness of COVID-19 boosters; XBB.1.5 subvariant
A recent study showed that absolute vaccine efficacy against COVID-19 hospitalization was higher in boosted individuals compared with those who received the primary series only.
XBB.1.5 finds ‘evolutionary sweet spot,’ becomes most transmissible subvariant
The XBB.1.5 omicron subvariant has evolved to become the most transmissible SARS-CoV-2 subvariant yet, rapidly replacing other variants, although its ultimate impact on the pandemic is unclear, according to experts.
‘Very reassuring’: COVID-19 vaccination safe for children after MIS-C
A study found no reported serious adverse events among children who received a COVID-19 vaccine after recovering from multisystem inflammatory syndrome in children, or MIS-C, according to results published in JAMA Network Open.
Study: Absolute effectiveness of recent COVID-19 booster against hospitalization is 81%
The absolute vaccine effectiveness of a recent first booster dose of COVID-19 messenger RNA vaccine against COVID-associated hospitalization is 81% compared with 46% for the primary series alone, researchers found.
Single dose of Jynneos mpox vaccine reduces hospitalization risk, disease severity
A single dose of the Jynneos mpox vaccine reduces hospitalization risk and disease severity, a study found, although researchers emphasized that people at risk for the disease should complete the two-dose vaccine series.
Top in ID: Asymptomatic COVID-19 testing; flu vaccination during 2021-2022 season
Researchers investigating the value of asymptomatic SARS-CoV-2 testing in a hospital setting reported that it provided clinically relevant data, and it may be more “clinically meaningful” to conduct among those who are not fully vaccinated.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read